PtX(TM) Human Anti-SARS-CoV-2 Spike RBD (CR3022) Recombinant Antibody, IgG1, Clone: [CR3022], Plant, Monoclonal

Product Overview

• Article Name: PtX(TM) Human Anti-SARS-CoV-2 Spike RBD (CR3022) Recombinant Antibody, IgG1, Clone: [CR3022], Plant, Monoclonal
• Biozol Catalog Number: CBX-CBT_A0006
• Supplier Catalog Number: CBT_A0006
• Alternative Catalog Number: CBX-CBT_A0006-100,CBX-CBT_A0006-20
• Manufacturer: Cape Biologix Technologies
• Host: Plant
• Category: Antikörper
• Application: ELISA, WB
• Species Reactivity: Human
• Immunogen: SARS-CoV-2 Spike protein (RBD of S1 subunit)
• Alternative Names: Anti-SARS-CoV-2 Receptor Binding Domain Antibody, Anti-RBD, Anti-RBD Antibody, CBT_A0005, Spike RBD, RBD Antibody, RBD Full Form, Receptor Binding Domain

Product Description

Recombinant human monoclonal antibody against the Receptor Binding Domain of SARS-CoV-2 Spike protein (subunit 1). This product is produced in Nicotiana benthamiana plants for use in Western blot and ELISA applications.

Product Properties

• Clonality: Monoclonal
• Concentration: 1.0 mg/ml
• Clone Designation: [CR3022]
• Molecular Weight: 150 kDa +
• Isotype: IgG1
• Tag: Human IgG1 Fc (chimeric fusion)
• UniProt: P59594
• Buffer: 0.1 M Phosphate Buffered Saline (PBS), pH = 7.4
• Source: Human
• Expression System: N. Benthamiana
• Purity: 99.30 % as determined by Mass Spectrometry.
• Form: Liquid
• Target: SARS-CoV-2 Spike protein (RBD of S1 subunit)
• Antibody Type: Recombinant Antibody

Application Notes

• Application Dilute: Optimal dilutions/concentrations should be determined by the user.
• Application Notes: Optimal dilutions/concentrations should be determined by the user.